Insider · CIK 0002007349
Schoch Charles
officer
Files at CADL (Candel Therapeutics, Inc.). First filing Jan 10, 2025, latest Mar 19, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $195k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 21Weak | sell 510b5-1 | CADL Candel Therapeutics, Inc. | $44k | 5,000 | -12% | +132% from low · -28% from high | |
| 43Moderate | sell 5 | CADL Candel Therapeutics, Inc. | $69k | 9,511 | -18% | +111% from low · -20% from high | |
| 44Moderate | sell 5 | CADL Candel Therapeutics, Inc. | $82k | 9,971 | -16% | +130% from low · -12% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,000 | $8.83 | $44k | 38,038 | Mar 19, 2025 |
| Feb 12, 2025 | CADL Candel Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +83,000 | $0.00 | $0 | 83,000 | Feb 14, 2025 |
| Jan 15, 2025 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock | -9,511 | $7.23 | $69k | 43,038 | Jan 17, 2025 |
| Jan 8, 2025 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock | -9,971 | $8.22 | $82k | 52,549 | Jan 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.